mPRISM for Cancer

"Yes, information on clinicaltrials.gov reveals that this study is currently seeking subjects. The trial was first listed on September 12, 2023 and last modified on January 31, 2024. It aims to recruit 120 participants from a single site."

"Indeed, information on clinicaltrials.gov confirms the ongoing recruitment of participants for this trial. The study was first listed on 9/12/2023 and last modified on 1/31/2024. Recruitment aims to enroll 120 individuals from a single research site."

"The research is open to enrollment for 120 cancer patients aged between 12 and 25 years. Essential requirements include a recent diagnosis of malignancy within the past six months that was treated with chemotherapy or radiation therapy at Seattle Children's Hospital (SCH). Additionally, applicants must be proficient in English or Spanish language and possess the cognitive ability necessary to engage in mHealth psychosocial intervention activities as well as interactive interviews."

"The primary focus of this clinical investigation, evaluated shortly after the intervention, is to gauge the appropriateness of the treatment. Secondary objectives encompass shifts in health-related quality of life as measured by The PedsQL 4.0 Generic and 3.0 Cancer Module comprising a comprehensive assessment covering physical, emotional, social well-being aspects alongside cancer-specific parameters like pain levels and cognitive functioning. Scores are converted into a range from 0-100 with higher scores indicating enhanced HRQOL. Additional secondary outcomes entail alterations in pain interference and intensity gauged through single queries using an 11-point Numeric Rating Scale (ranging from 0"

"Patients aged between 12 and 25 are sought for participation in this research project. Notably, there exist 59 studies catering to individuals under the age of majority along with an additional 451 focused on elderly patients over the age of retirement."